Literature DB >> 17105866

Tumour necrosis factor inhibition causing psoriasis? A more plausible explanation exists.

J D Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17105866      PMCID： PMC1798459          DOI： 10.1136/ard.2006.054833

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Reiter's syndrome.

Authors:  Joseph M Schneider; Jeanette H Matthews; Bradley S Graham
Journal:  Cutis       Date:  2003-03

2.  The mucocutaneous lesions of Reiter's syndrome.

Authors:  M M MONTGOMERY; R M POSKE; E M BARTON; D T FOXWORTHY; L A BAKER
Journal:  Ann Intern Med       Date:  1959-07       Impact factor: 25.391

3.  New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.

Authors:  S Kary; M Worm; H Audring; D Huscher; M Renelt; H Sörensen; E Ständer; U Maass; H Lee; W Sterry; G-R Burmester
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

4.  Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha.

Authors:  Tatsuya Ishihara; Miho Aga; Keiko Hino; Chie Ushio; Mutsuko Taniguchi; Kanso Iwaki; Masao Ikeda; Masashi Kurimoto
Journal:  Biomed Res       Date:  2005-08       Impact factor: 1.203

5.  Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression.

Authors:  H C Gérard; P J Branigan; H R Schumacher; A P Hudson
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

6.  The clinical diagnosis of Reiter's syndrome. Ophthalmic and nonophthalmic aspects.

Authors:  D A Lee; S M Barker; W P Su; G L Allen; T J Liesegang; D M Ilstrup
Journal:  Ophthalmology       Date:  1986-03       Impact factor: 12.079

7.  Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.

Authors:  P P Sfikakis; A Iliopoulos; A Elezoglou; C Kittas; A Stratigos
Journal:  Arthritis Rheum       Date:  2005-08

8.  Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis.

Authors:  J S Gaston; C Cox; K Granfors
Journal:  Arthritis Rheum       Date:  1999-10

9.  Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats.

Authors:  Robert D Inman; Basil Chiu
Journal:  Arthritis Rheum       Date:  2006-02

Review 10.  Persistent Chlamydiae and chronic arthritis.

Authors:  Cheryl Villareal; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Arthritis Res       Date:  2001-10-08
  10 in total
  2 in total

1.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Authors:  Sara Jiayang Li; Lourdes M Perez-Chada; Joseph F Merola
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.